Paralysis News and Research RSS Feed - Paralysis News and Research

Paralysis is the loss of muscle function in part of your body. It happens when something goes wrong with the way messages pass between your brain and muscles. Paralysis can be complete or partial. It can occur on one or both sides of your body. It can also occur in just one area, or it can be widespread. Paralysis of the lower half of your body, including both legs, is called paraplegia. Paralysis of the arms and legs is quadriplegia.

InVivo Therapeutics to sponsor Working 2 Walk symposium

InVivo Therapeutics Holdings Corp., a developer of groundbreaking technologies for the treatment of spinal cord injuries and other neurotrauma conditions, today announced that the Company is the Title Sponsor of the 8th annual Working 2 Walk Science & Advocacy Symposium taking place September 27-28, 2013 at the Boston Convention & Exhibit Center in Boston, MA. [More]

Sterling Insurance increases availability of Sterling Critical Condition to 31 states

Sterling Insurance is proud to announce the expansion of Sterling Critical Condition in 18 additional states, increasing the availability to 31 states. [More]

Study reveals barriers among African-Americans in getting help for stroke

African-Americans know the signs of stroke, but concerns about medical cost, ambulance response time and unfamiliarity with the need for prompt hospital care impacted whether they called 9-1-1 immediately. [More]
Tel Aviv University researchers invent a method for repairing damaged peripheral nerves

Tel Aviv University researchers invent a method for repairing damaged peripheral nerves

Some parts of the body, like the liver, can regenerate themselves after damage. But others, such as our nervous system, are considered either irreparable or slow to recover, leaving thousands with a lifetime of pain, limited mobility, or even paralysis. [More]
Scientists spell out pivotal role of Peli1 in mouse model of multiple sclerosis

Scientists spell out pivotal role of Peli1 in mouse model of multiple sclerosis

Scientists have identified an influential link in a chain of events that leads to autoimmune inflammation of the central nervous system in a mouse model of multiple sclerosis. [More]
Investigational treatment for ALS passes early phase clinical trial for safety

Investigational treatment for ALS passes early phase clinical trial for safety

An investigational treatment for an inherited form of Lou Gehrig's disease has passed an early phase clinical trial for safety, researchers at Washington University School of Medicine in St. Louis and Massachusetts General Hospital report. [More]
Study provides medical chemists with tools to design safer drugs, predict their side effects

Study provides medical chemists with tools to design safer drugs, predict their side effects

Yellow vision, pseudo-pulmonary obstruction, involuntary body movements, respiratory paralysis. These are some of the 1,600 known side effects (SEs) produced by drugs. [More]
Clinical Research Forum selects sickle cell project among 'Top 10' clinical research achievements of 2012

Clinical Research Forum selects sickle cell project among 'Top 10' clinical research achievements of 2012

Pioneering research led by Johns Hopkins scientists on the use of partially matched bone marrow transplants to wipe out sickle cell disease has been selected as one of the Top 10 Clinical Research Achievements of 2012 by the Clinical Research Forum. [More]
Clinical Research Forum honors studies with potential to benefit human health and welfare

Clinical Research Forum honors studies with potential to benefit human health and welfare

Ten of the most outstanding clinical research projects from institutions around the country have been selected to receive the Clinical Research Forum's Annual Top 10 Clinical Research Achievement Awards. [More]
Three MGH projects named among Top 10 Clinical Research Achievements of 2012

Three MGH projects named among Top 10 Clinical Research Achievements of 2012

Three projects led by Massachusetts General Hospital investigators have been named among the Clinical Research Forum's Top 10 Clinical Research Achievements of 2012. [More]
Obstructive salivary gland disease treatment: an interview with Thomas Cherry, Cook Medical

Obstructive salivary gland disease treatment: an interview with Thomas Cherry, Cook Medical

Everyone is familiar with urinary stones (kidney stones). The same thing can actually happen in your salivary ducts. These types of stones and strictures occur not nearly as frequently as kidney stones but they still occur quite often. The latest data we have seen showed about 1 in 5,000 patients actually have some type of obstructive salivary duct disorder. [More]
Spencer Trask applauds InVivo for getting FDA approval to test biopolymer scaffold in humans

Spencer Trask applauds InVivo for getting FDA approval to test biopolymer scaffold in humans

Spencer Trask, a venture capital firm focused on developing big ideas into world-changing companies, congratulates InVivo Therapeutics, for its recent approvals from the U.S. Food and Drug Administration. [More]
People to participate in Rally for Medical Research to raise awareness of NIH funding

People to participate in Rally for Medical Research to raise awareness of NIH funding

On April 8 at 11 a.m., thousands of people will gather on the Carnegie Library grounds to participate in the Rally for Medical Research to raise awareness of the critical need to make funding for the National Institutes of Health a priority. [More]
GPEI announces 'endgame' plan to eradicate polio by 2018

GPEI announces 'endgame' plan to eradicate polio by 2018

"A new global plan aims to end most cases of polio by late next year, and essentially eradicate the paralyzing disease by 2018 -- if authorities can raise the $5.5 billion needed to do the work, health officials said Tuesday," the Associated Press reports (Neergaard, 4/2). [More]
Clinical trial signals new era in treatment of neurodegererative disorders

Clinical trial signals new era in treatment of neurodegererative disorders

The initial clinical trial of a novel approach to treating amyotrophic lateral sclerosis - blocking production of a mutant protein that causes an inherited form of the progressive neurodegererative disease - may be a first step towards a new era in the treatment of such disorders. [More]

Research findings shed light on how neurons translate sensory input into actions

New research by scientists at the University of Massachusetts Medical School shows at the single cell level how an external stimulus sets off a molecular chain reaction in the transparent roundworm C. elegans, a process in which a single neurotransmitter coordinates and times two separate actions. [More]
Salk neuroscientist applauds launch of BRAIN Initiative

Salk neuroscientist applauds launch of BRAIN Initiative

Salk neuroscientist Terrence J. Sejnowski joined President Barack Obama in Washington, D.C., on April 2, 2013, at the launch of the Brain Research through Advancing Innovative Neurotechnologies Initiative-a major Administration neuroscience effort that advances and builds upon collaborative scientific work by leading brain researchers such as Salk's own Sejnowski. [More]
Kavli Foundation applauds launch of new brain research initiative

Kavli Foundation applauds launch of new brain research initiative

The Kavli Foundation applauds today's launch by President Obama of his Administration's ambitious research effort to understand the brain by deciphering the brain's activity that gives rise to our perceptions, our experiences and our consciousness. [More]

Study provides important insight into how BMT treatment works in patients with MS

A new study by Multiple Sclerosis researchers at three leading Canadian centres addresses why bone marrow transplantation has positive results in patients with particularly aggressive forms of MS. [More]
Gladstone investigator to receive Essey Award for fight against amyotrophic lateral sclerosis

Gladstone investigator to receive Essey Award for fight against amyotrophic lateral sclerosis

Shinya Yamanaka, MD, PhD, a senior investigator at the Gladstone Institutes, next month will receive the Essey Award for his "Commitment to a Cure" from The ALS Association Golden West Chapter. [More]